Trexquant Investment’s AstraZeneca AZN Stock Holding History

Trexquant Investment’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20,132	Closed	-$2.96M	–	1516
2025 Q1	$2.96M	Buy	+20,132	New	+$2.91M	0.03%	724
2024 Q3	–	Sell	-45,441	Closed	-$7.09M	–	1531
2024 Q2	$7.09M	Buy	+45,441	New	+$6.84M	0.11%	294
2023 Q3	–	Sell	-15,425	Closed	-$2.21M	–	1448
2023 Q2	$2.21M	Buy	+15,425	New	+$2.27M	0.06%	459
2022 Q3	–	Sell	-5,048	Closed	-$667K	–	1353
2022 Q2	$667K	Buy	+5,048	New	+$662K	0.03%	682
2021 Q1	–	Sell	-33,602	Closed	-$3.36M	–	1116
2020 Q4	$3.36M	Buy	+33,602	New	+$3.56M	0.36%	62
2020 Q3	–	Sell	-16,560	Closed	-$1.75M	–	1189
2020 Q2	$1.75M	Buy	+16,560	New	+$1.71M	0.12%	231
2019 Q3	–	Sell	-28,703	Closed	-$2.37M	–	859
2019 Q2	$2.37M	Sell	28,703 -29,038	-50%	-$2.28M	0.21%	148
2019 Q1	$4.67M	Buy	+57,741	New	+$4.55M	0.33%	68
2017 Q4	–	Sell	-9,529	Closed	-$646K	–	1039
2017 Q3	$646K	Buy	9,529 +2,929	+44%	+$185K	0.16%	184
2017 Q2	$450K	Buy	+6,600	New	+$431K	0.12%	290
2016 Q2	–	Sell	-37,350	Closed	-$2.1M	–	871
2016 Q1	$2.1M	Buy	37,350 +24,328	+187%	+$1.46M	0.25%	93
2015 Q4	$884K	Buy	+13,022	New	+$854K	0.08%	436
2015 Q1	–	Sell	-6,600	Closed	-$464K	–	980
2014 Q4	$464K	Buy	+6,600	New	+$473K	0.08%	498

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Trexquant Investment's AZN Position: Q2 2025 in Review

Trexquant Investment sold out of AstraZeneca (AZN) in Q2 2025, closing a stake of 20,132 shares — an estimated $2.96M sold.

Trexquant Investment first reported a position in AZN in Q4 2014 and held it in 13 quarters. The position peaked at $7.09M in Q2 2024. 1,222 funds tracked by Wall St. Rank hold AZN as of Q2 2025.

Trexquant Investment reported no remaining AstraZeneca position as of Q2 2025 after selling out during the quarter.
Trexquant Investment sold 20,132 AstraZeneca shares in Q2 2025, an estimated $2.96M.
Trexquant Investment first reported a position in AstraZeneca in Q4 2014 and held it in 13 quarters.
Trexquant Investment's AstraZeneca position peaked at $7.09M in Q2 2024.
1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2025.

Based on Trexquant Investment's 13F filing for Q2 2025, filed 12 Aug 2025.